Clinical Trials Logo

Emergency Department clinical trials

View clinical trials related to Emergency Department.

Filter by:

NCT ID: NCT03499301 Completed - Chronic Pain Clinical Trials

Description of Chronic Pain in Emergencies Room and Medical Care Modalities

CHRODOLURG
Start date: January 3, 2018
Phase:
Study type: Observational

The rate of patients with chronic pain (CP) is 40% in patients with acute pain in emergency department (ED). Patients with CP come more frequently to ED than patients without CP. Reasons for their visit to ED are often in relation with this CP. Few studies have been interested to management modalities of these patients in ED. The investigators are going to realize a prospective observational study in one center. The hypothesis is that patients with chronic pain are less satisfied of ED management that patients without CP.

NCT ID: NCT03082417 Completed - Pain, Acute Clinical Trials

The PAINFREE Initiative, a Stepped Wedge Cluster Randomized Trial

PAINFREE
Start date: March 1, 2016
Phase: N/A
Study type: Interventional

The PAINFREE (Improving PAIN control following FRactures; towards an Elder-friendly Emergency department) Initiative is a patient-centered multifaceted intervention which aims to improve pain management in patients 75 years and older presenting with a fracture at 7 Emergency Department of participating Montreal hospitals: 1. Montreal General Hospital 2. Royal Victoria Hospital 3. Ste Mary's Hospital 4. Hôpital de Verdun 5. Hôpital du Sacré-Coeur de Montréal 6. Jewish General Hospital 7. Lakeshore General Hospital

NCT ID: NCT03051737 Recruiting - Hospitalization Clinical Trials

Development and Validation of a Regional Multi-scale System for the Prediction of the Patient Flow in the Emergencies and the Need for Hospitalization

PRED-URG
Start date: June 1, 2021
Phase:
Study type: Observational

The main objective of this retrospective study is to validate a prediction system of emergencies department (ED) attendance on a wide range of time and the need for hospitalization, at various levels of perimeter (with all emergency departments or one ED in particular), with all patients or with one sub-group of patients (age, gravity, care).

NCT ID: NCT02903017 Completed - Clinical trials for Gastrointestinal Hemorrhage

Local Administration of Tranexamic Acid in Upper Gastrointestinal Hemorrhage

Start date: September 2016
Phase: Phase 4
Study type: Interventional

Upper gastrointestinal hemorrhage is a frequently diagnosis in emergency departments. Although new drugs and endoscopic techniques were easily applied in various settings in this condition, the role of local administered therapies such as antifibrinolytic agents remain unclear. The investigators aimed to compare standard therapy (proton pump inhibitors, endoscopic treatments etc.) and standard therapy + local administered tranexamic acid in upper gastrointestinal hemorrhage in a double-blind, randomized trial.

NCT ID: NCT02307136 Completed - Clinical trials for Intensive Care Units

Evaluation of the Impact of Within-hospital Trajectories of Patients Admitted in Intensive Care Units (ICU) From Emergency Departments

SUREA
Start date: January 2013
Phase: N/A
Study type: Observational

This multicenter cohort aims to assess the impact of within-hospital trajectories of patients admitted in intensive care units from emergency departments on vital prognosis of patients, duration of hospital stay and hospital costs. As secondary objectives, the study will: - assess the impact of clinical and demographic characteristics on hospital trajectories of patients. - assess the impact of emergency units workload, beds availability in medical units and in intensive care units, and global hospital organisation on patients care trajectories.

NCT ID: NCT02210637 Recruiting - Mortality Clinical Trials

Non Attendance at Scheduled Appointments as a Marker of Mortality and Hospital Admission

Start date: December 2015
Phase: N/A
Study type: Observational

To evaluate the association of non attendance at scheduled appointments with visits in the emergency department, hospitalizations and mortality during one year follow up.

NCT ID: NCT01065675 Terminated - Clinical trials for Emergency Department

Medication Histories Conducted by Nurses (RNs), Pharmacy Techs (CPhTs) & Pharmacists (RPhs)

Start date: February 2010
Phase: N/A
Study type: Interventional

Up to 50% of medication errors and 20% of adverse drug reactions (ADRs) in the hospital setting are estimated to be related to communication issues regarding patient medications at various transition points of care from admission to discharge. The Joint Commission (TJC) requires accurate and complete medication reconciliation occur at each transition point throughout hospitalization. Evidence from NQF demonstrates pharmacists (RPh) are the most effective medication management team leaders in the implementation of medication management practices and design of medication error reduction strategies; medication reconciliation is one of the five safety objectives pharmacists are recommended to lead. In addition, the Massachusetts Coalition for the Prevention of Medical Errors states strong evidence supports the use of pharmacy technicians (CPhT) in conjunction with pharmacists in completing accurate medication histories. WMC nurses (RN) currently are involved in the medication reconciliation process. In 2009, a Medication Use Evaluation (MUE) of Medication Reconciliation Accuracy found a 67% medication error rate on admission determined by comparing the nurse-obtained medication history to the pharmacist-obtained medication history. The number of home medications identified by the pharmacist compared to the nurse was 411 versus 312 (p<0.0001). The total percentage of medication errors prevented by the pharmacist was 66.2. Using the VA Healthcare Failure Mode Effects Analysis - HFMEAâ„¢ Hazard Scoring Matrix, 3 independent pharmacist reviewers found that 18% of patients interviewed had a score greater than 7, and 3 patients had a score of 12 (major/probable), if the discrepancies would not have been identified and corrected by the pharmacist conducting the admission medication reconciliation audit. The same patients' discharge medication reconciliation and discharge medication lists were retrospectively reviewed for the MUE, and the total percentage of patients with medication errors on discharge was 43%.

NCT ID: NCT00942955 Completed - Length of Stay Clinical Trials

Point-Of-Care Chemistry Test (POCT) Effect on the Emergency Department (ED)

Start date: January 2009
Phase: N/A
Study type: Observational

The hypothesis of this study is that POCT will shorten ED turn-around-time (TAT) such as blood drawing TAT, lab TAT, and decision TAT.